• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Digital diagnostics and artificial intelligence in prostate cancer treatment in 5 years from now.

作者信息

Cimadamore Alessia, Cheng Liang, Scarpelli Marina, Lopez-Beltran Antonio, Montironi Rodolfo

机构信息

Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Transl Androl Urol. 2021 Mar;10(3):1499-1505. doi: 10.21037/tau-2021-01.

DOI:10.21037/tau-2021-01
PMID:33850784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8039614/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/562acb774d99/tau-10-03-1499-fe.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/ea6a59358853/tau-10-03-1499-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/28ae673e6a2d/tau-10-03-1499-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/75d8d502644b/tau-10-03-1499-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/787c6e32dad4/tau-10-03-1499-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/b502ae72cc84/tau-10-03-1499-fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/4febf163038c/tau-10-03-1499-fb.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/87b8595577b3/tau-10-03-1499-fc.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/0adaf6c745e1/tau-10-03-1499-fd.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/562acb774d99/tau-10-03-1499-fe.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/ea6a59358853/tau-10-03-1499-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/28ae673e6a2d/tau-10-03-1499-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/75d8d502644b/tau-10-03-1499-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/787c6e32dad4/tau-10-03-1499-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/b502ae72cc84/tau-10-03-1499-fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/4febf163038c/tau-10-03-1499-fb.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/87b8595577b3/tau-10-03-1499-fc.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/0adaf6c745e1/tau-10-03-1499-fd.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/8039614/562acb774d99/tau-10-03-1499-fe.jpg

相似文献

1
Digital diagnostics and artificial intelligence in prostate cancer treatment in 5 years from now.从现在起五年后前列腺癌治疗中的数字诊断与人工智能。
Transl Androl Urol. 2021 Mar;10(3):1499-1505. doi: 10.21037/tau-2021-01.
2
Artificial Intelligence in Skin Cancer Diagnostics: The Patients' Perspective.皮肤癌诊断中的人工智能：患者视角
Front Med (Lausanne). 2020 Jun 2;7:233. doi: 10.3389/fmed.2020.00233. eCollection 2020.
3
Point-of-Care Digital Cytology With Artificial Intelligence for Cervical Cancer Screening in a Resource-Limited Setting.人工智能辅助即时细胞学检测在资源有限环境下用于宫颈癌筛查
JAMA Netw Open. 2021 Mar 1;4(3):e211740. doi: 10.1001/jamanetworkopen.2021.1740.
4
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives.人工智能与机器学习在前列腺癌患者管理中的应用——当前趋势与未来展望
Diagnostics (Basel). 2021 Feb 20;11(2):354. doi: 10.3390/diagnostics11020354.
5
The Artificial Intelligence in Digital Pathology and Digital Radiology: Where Are We?数字病理学和数字放射学中的人工智能：我们目前处于什么阶段？
Healthcare (Basel). 2020 Dec 31;9(1):30. doi: 10.3390/healthcare9010030.
6
A brief introduction to concepts and applications of artificial intelligence in dental imaging.人工智能在牙科影像学中的概念与应用简介。
Oral Radiol. 2021 Jan;37(1):153-160. doi: 10.1007/s11282-020-00468-5. Epub 2020 Aug 16.
7
Contemporary application of artificial intelligence in prostate cancer: an i-TRUE study.人工智能在前列腺癌中的当代应用：一项i-TRUE研究。
Ther Adv Urol. 2021 Jan 23;13:1756287220986640. doi: 10.1177/1756287220986640. eCollection 2021 Jan-Dec.
8
Implementing Artificial Intelligence and Digital Health in Resource-Limited Settings? Top 10 Lessons We Learned in Congenital Heart Defects and Cardiology.在资源有限的环境中实施人工智能和数字健康？我们在先天性心脏病和心脏病学中获得的十大经验教训。
OMICS. 2020 May;24(5):264-277. doi: 10.1089/omi.2019.0142. Epub 2019 Oct 8.
9
Artificial intelligence for assisting diagnostics and assessment of Parkinson's disease-A review.用于辅助帕金森病诊断和评估的人工智能——综述
Clin Neurol Neurosurg. 2019 Sep;184:105442. doi: 10.1016/j.clineuro.2019.105442. Epub 2019 Jul 16.
10
Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma.系统评价皮肤镜检查和数字皮肤镜检查/人工智能在黑色素瘤诊断中的应用。
Br J Dermatol. 2009 Sep;161(3):591-604. doi: 10.1111/j.1365-2133.2009.09093.x. Epub 2009 Mar 19.

引用本文的文献

1
MRI and Targeted Biopsy Essential Tools for an Accurate Diagnosis and Treatment Decision Making in Prostate Cancer.MRI与靶向活检：前列腺癌准确诊断及治疗决策的关键工具
Diagnostics (Basel). 2021 Aug 27;11(9):1551. doi: 10.3390/diagnostics11091551.
2
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation.2021年前列腺癌：预后和治疗生物标志物评估的新进展
Cancers (Basel). 2021 Jul 11;13(14):3471. doi: 10.3390/cancers13143471.

本文引用的文献

1
Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?肾细胞癌的辅助治疗：抑制血管内皮生长因子（VEGF）是正确策略吗？
Transl Androl Urol. 2021 Mar;10(3):1581-1587. doi: 10.21037/tau-20-1125.
2
Current and future perspectives of digital microscopy with fluorescence confocal microscope for prostate tissue interpretation: a narrative review.用于前列腺组织解读的荧光共聚焦显微镜数字显微镜的现状与未来展望：一篇叙述性综述
Transl Androl Urol. 2021 Mar;10(3):1569-1580. doi: 10.21037/tau-20-1237.
3
Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States.
叙述性综述：预测美国前列腺癌的未来分子和临床特征
Transl Androl Urol. 2021 Mar;10(3):1562-1568. doi: 10.21037/tau-20-1439.
4
A narrative review of individualized treatments of genitourinary tumors: is the future brighter with molecular evaluations?泌尿生殖系统肿瘤个体化治疗的叙述性综述：分子评估会让未来更光明吗？
Transl Androl Urol. 2021 Mar;10(3):1553-1561. doi: 10.21037/tau-20-1185.
5
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review.转移性尿路上皮癌中走向个性化治疗的TNM分期：未来会怎样？——一篇叙述性综述
Transl Androl Urol. 2021 Mar;10(3):1541-1552. doi: 10.21037/tau-20-1109.
6
Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?前列腺癌分级系统的叙述性综述：Gleason评分会被分级组取代吗？
Transl Androl Urol. 2021 Mar;10(3):1530-1540. doi: 10.21037/tau-20-853.
7
Narrative review: update on immunotherapy and pathological features in patients with bladder cancer.叙述性综述：膀胱癌患者免疫治疗及病理特征的最新进展
Transl Androl Urol. 2021 Mar;10(3):1521-1529. doi: 10.21037/tau-20-1436.
8
Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.迈向世界卫生组织肾细胞肿瘤新分类：临床医生需要了解的内容——一篇叙述性综述
Transl Androl Urol. 2021 Mar;10(3):1506-1520. doi: 10.21037/tau-20-1150.
9
Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study.荧光共聚焦显微镜数字活组织检查在实时有效诊断前列腺癌中的应用：一项前瞻性、对照研究。
Eur Urol Oncol. 2021 Oct;4(5):784-791. doi: 10.1016/j.euo.2020.08.009. Epub 2020 Sep 18.
10
Considerations on current and future issues related to reproducibility and accuracy in prostate cancer grading.关于前列腺癌分级中与可重复性和准确性相关的当前及未来问题的思考
Virchows Arch. 2021 Feb;478(2):375-377. doi: 10.1007/s00428-020-02913-6. Epub 2020 Aug 17.